Trinity Biotech PLC Files 6-K for Q2 2025
Ticker: TRIB · Form: 6-K · Filed: Dec 23, 2025 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | Dec 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, reporting
TL;DR
TRINITY BIOTECH PLC filed a 6-K for Q2 2025, confirming 20-F annual report filings.
AI Summary
Trinity Biotech plc filed a Form 6-K on December 23, 2025, reporting for the period ending June 30, 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. The report covers the month of December 2025 and is related to their operations in Ireland.
Why It Matters
This filing provides an update on Trinity Biotech's reporting status and confirms their adherence to SEC regulations for foreign private issuers, impacting investor transparency.
Risk Assessment
Risk Level: low — This is a routine periodic filing by a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 0001178913-25-004104 (accession_number) — Filing Accession Number
- 20251223 (date) — Filing Date
- 20250630 (date) — Period of Report
- IDA Business Park Bray, Co. Wicklow Ireland (location) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of December 2025.
What is the reporting period for this filing?
The Conformed Period of Report is 20250630, indicating it relates to the second quarter of 2025.
Does Trinity Biotech plc file annual reports under Form 20-F or 40-F?
Yes, the registrant indicates by check mark that it files annual reports under cover of Form 20-F.
Where are Trinity Biotech plc's principal executive offices located?
The principal executive offices are located at IDA Business Park, Bray, Co. Wicklow, Ireland.
What is the SIC code for Trinity Biotech plc?
The Standard Industrial Classification (SIC) code is 2835, for In Vitro & In Vivo Diagnostic Substances.
Filing Stats: 332 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2025-12-23 07:31:14
Filing Documents
- zk2534106.htm (6-K) — 20KB
- exhibit_99-1.htm (EX-99.1) — 1624KB
- exhibit_99-2.htm (EX-99.2) — 105KB
- 0001178913-25-004104.txt ( ) — 9804KB
- trib-20250630.xsd (EX-101.SCH) — 177KB
- trib-20250630_cal.xml (EX-101.CAL) — 56KB
- trib-20250630_def.xml (EX-101.DEF) — 237KB
- trib-20250630_lab.xml (EX-101.LAB) — 1631KB
- trib-20250630_pre.xml (EX-101.PRE) — 361KB
- zk2534106_htm.xml (XML) — 2048KB
Management's Discussion and Analysis of Results of Operations, Liquidity and Cash Flows
Management's Discussion and Analysis of Results of Operations, Liquidity and Cash Flows
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC (Registrant) By: /s/ Susan O'Connor Susan O'Connor Interim Chief Financial Officer Date: December 23, 2025